- Our mission is to promote open innovation in Asia in order to realize “drug discovery that originates in Asia".
- By establishing an“Information-Sharing System”as DSANA, we promote the exchange of drug seeds between academia and research alliance representatives in pharmacompanies.
- Based on the the Drug Seeds Alliance Network Japan (DSANJ) system, we first promote to set up DSAN system to each Asian companies with the domestic supporting organization,and as next step, we connect each DSAN X system to DSANA.
2021-08-02 DSANA webpage open.
- To organize the information of drug discovery player (Pharmaceutical, Biotech company, etc.) in Asia, and To keep academia scientist in Asia informed about the company's existence and activity.
- To collect and register Drug seeds information in Asia in collaboration with relevant bodies of APAC, and to promote to set up industry drivin alliance formation based on the seeds.
- To encourage internal drug discovery incubation system in each Asian country by DSANJ system.
- Public Relations that inform academic scientists in Asia to an enterprise activity of drug discovery.
- DSANA Database for matching up between Seeds proposer and buyer (Pharma, Biotech etc..) in Asia.
- Know how sharing for development of internal drug seeds incubation system
- Organizer
Osaka Chamber of Commerce and Industry
Japan Pharmaceutical Manufacturers Association
- APAC DA relevant body
China: Under registration
Japan: Osaka Chamber of Commerce and Industry
Japan Pharmaceutical Manufacturers Association
Korea: Under registration
Thailand: Under registration
- Seeds Proposer (Academia, Biotech, etc.)
- Buyer (Pharmaceutical company, Biotech, etc.)
- Our mission is to promote open innovation in Asia in order to realize “drug discovery that originates in Asia".
- By establishing an“Information-Sharing System”as DSANA, we promote the exchange of drug seeds between academia and research alliance representatives in pharmacompanies.
- Based on the the Drug Seeds Alliance Network Japan (DSANJ) system, we first promote to set up DSAN system to each Asian companies with the domestic supporting organization,and as next step, we connect each DSAN X system to DSANA.
- To find potential partner in Asia
- To appeal your research result and its progress to industrial side
- To join the Biz meeting with pharmaceutical company in Asia (e.g. Video conference, matching event)
1) To access to APAC relevant body in domestic
2) To register and edit the proposal materials with DSANJ guideline
3) To join the Face to Face meeting via Video conference or matching event
China: Under registration
Japan: Osaka Chamber of Commerce and Industry
Korea: Under registration
Taiwan: Under registration
Thailand: Under registration
- To find potential Drug seeds or/and technology holder inventor in Asia
- To advertise your company's profile and its strength of R&D to academia in Asia
- To join Biz meeting with support of APAC relevant body (e.g. Face to Face, Video conference...)
1) To access to APAC relevant body in domestic
2) To register and edit the corporate profile and its strength of R&D
3) To join the Face to Face meeting via Video conference or matching event
China: Under registration
Japan: DSANJ (Osaka Chamber of Commerce and Industry)
Korea: Under registration
Taiwan: Under registration
Thailand: Under registration
APAC is an industry-driven initiative led by R&D-based pharmaceutical associations from Asian economies, aiming to fulfill to expedite the launch of innovative medicines for the peoples in Asia
Goal of APACAPAC proposes the concept of “Access to Innovative Medicines (ATIM)”, the achievement of which is the ultimate goal of APAC, as illustrated below with a description of the scope of priorities that APAC should address. Ongoing activities in the fields of “Drug Discovery Alliances (DA)” and “Regulations and Approvals (RA)” are the priorities that APAC has been tackling as a first step towards the achievement of ATIM.
APAC will continue to take up other priorities step by step as it contributes to the health of the people in Asia.
http://www.jpma.or.jp/english/
About JPMAThe Japan Pharmaceutical Manufacturers Association (JPMA) is a voluntary association comprising 74 research-oriented pharmaceutical companies (as of April, 2021).
Through mutual information sharing and close collaboration with each member organization, JPMA continues to act globally for the advancement of medical treatments for patients worldwide.
http://www.jpma.or.jp/english/
About OCCISupported by respectable members of various scales with wide-ranging lines of business, the Osaka Chamber of Commerce and Industry (OCCI) represents the Osaka-Kansai region as a major economic organization. The mission of OCCI is to contribute to realization of a revitalized economic society, reconversion of industrial structure, enhancement of international competitiveness, renovated business management by member companies and creation of business opportunities.
2-8 Honmachi-Bashi, Chuo-ku, Osaka, Japan 540-0029
Tel +81-6-6944-6484 Fax +81-6-6944-6249
E-mail: souyaku@osaka.cci.or.jp